With the rise of renin-angiotensin-targeted drugs, therapies that specifically target only the sympathetic nervous system have significantly decreased in use, even though one of the most verified findings in essential hypertension is that increased sympathetic nervous system activity is associated with the onset of hypertension (12–16). This evidence concerns the gene REN and hypertensive disorder.